HealWELL AI Inc

HEALWELL acquires Toronto-based Mutuo Health Solutions! View details here.

HEALWELL AI Appoints Anthony Lam as New Chief Financial Officer

  • Experienced finance and technology executive Anthony Lam joins as the Company’s new Chief Financial Officer. 
  • Mr. Lam will replace Mr. Scott Nirenberski who has been CFO since Sept 2020.  

TORONTO, ON, June 4, 2024 – HEALWELL AI Inc. (“HEALWELL” or the “Company”) (TSX: AIDX) (OTCQX: HWAIF), an AI and data science company focused on preventative care, is pleased to announce the appointment of Anthony Lam as Chief Financial Officer (CFO), effective immediately. Reporting directly to Dr. Alexander Dobranowski, CEO of HEALWELL, Mr. Lam will have responsibility for all finance, accounting, financial reporting, audit, tax, and capital planning functions. Mr. Lam assumes the Chief Financial Officer role from Scott Nirenberski who has been the company’s CFO for the past 4 years. 

Dr. Alexander Dobranowski, CEO of HEALWELL, commented, “We are both thrilled and proud to welcome Anthony to HEALWELL’s executive team. Anthony’s previous financial experience as the CFO of multiple private and publicly listed technology companies will be a valuable asset to the company as we enter HEALWELL’s next stage of growth. I also want to thank Scott Nirenberski, who served as our CFO since September 2020 and helped support the transition from the predecessor company MCI OneHealth to the launch of HEALWELL in October 2023. We are very appreciative for Scott’s years of service and support and wish him well in his future endeavors.” 

Anthony Lam is an Executive Business Leader with over 20 years of international senior finance and operational leadership experience in several high growth public and private organizations spanning Cybersecurity, Digital Health, Digital Media, Loyalty, SaaS, Software, Gaming, Internet Commerce and Technology Licensing sectors. With a long-standing background in analytics, treasury and capital markets, Anthony’s list of accomplishments includes successful mergers and acquisition activity, debt and capital fundraising and public listings on the Toronto, London, and NASDAQ exchanges. 

Previously, Mr. Lam worked as the CFO of multiple private and publicly listed technology companies. Most recently he was the CFO of eSentire, a cybersecurity company protecting the critical data and applications of 2000+ organizations, and the CFO of Newtopia, a publicly listed technology-enabled habit change provider focused on disease prevention and reducing the cost of care for health insurers. Previously, Mr. Lam was also the CFO of TSX and Nasdaq listed company, Points.com.  Mr. Lam is a CPA and holds a Bachelor of Commerce degree from the University of Toronto. 

Mr. Lam commented, “I am pleased to be joining the HEALWELL team and excited to help the company in its goal of improving healthcare through the early identification and detection of disease. I was drawn to HEALWELL because of the exceptional team and the opportunity to be a part of a rapidly growing company implementing AI into the healthcare sector. I’m focused on building resilient organizations, rooted with firm financial discipline, leveraging technology to improve efficiency and a continuous desire to inspire exceptional performance. I look forward to working with the HEALWELL team as we look to achieve new milestones in the years ahead.” 

 

Dr. Alexander Dobranowski 
Chief Executive Officer 
HEALWELL AI Inc. 

About HEALWELL AI

HEALWELL is a healthcare technology company focused on AI and data science for preventative care. Its mission is to improve healthcare and save lives through early identification and detection of disease. Using its own proprietary technology, the Company is developing and commercializing advanced clinical decision support systems that can help healthcare providers detect rare and chronic diseases, improve efficiency of their practice and ultimately help improve patient health outcomes. HEALWELL is executing a strategy centered around developing and acquiring technology and clinical sciences capabilities that complement the Company’s road map. HEALWELL is publicly traded on the Toronto Stock Exchange (the “TSX”) under the symbol “AIDX” and on the OTC Exchange under the symbol “HWAIF”. To learn more about HEALWELL, please visit healwell.ai

Forward-Looking Statements

Certain statements in this press release, constitute “forward-looking information” and “forward looking statements” (collectively, “forward looking statements”) within the meaning of applicable Canadian securities laws, such as the appointment and responsibilities of the new Chief Financial Officer of the Company, and are based on assumptions, expectations, estimates and projections as of the date of this press release. Forward-looking statements are often, but not always, identified by words or phrases such as “effective”, “pursue”, “goal”, “build”, “leverage”, “desire”, “inspire”, “achieve”, “improve”, “future”, “plan”, “opportunities”, or variations of such words and phrases or statements that certain future conditions, actions, events or results “will”, “may”, “could”, “would”, “should”, “might” or “can” be taken, occur or be achieved, or the negative of any of these terms . Forward-looking statements are necessarily based upon management’s perceptions of historical trends, current conditions and expected future developments, as well as a number of specific factors and assumptions that, while considered reasonable by HEALWELL as of the date of such statements, are outside of HEALWELL’s control and are inherently subject to significant business, economic and competitive uncertainties and contingencies which could result in the forward-looking statements ultimately being entirely or partially incorrect or untrue. Forward looking statements contained in this press release are based on various assumptions, including, but not limited to, the following: changes in personnel and senior management, the stability of general economic and market conditions;  HEALWELL’s ability to comply with applicable laws and regulations; HEALWELL’s continued compliance with third party intellectual property rights; and that the risk factors noted below, collectively, do not have a material impact on HEALWELL’s business, operations, revenues and/or results. By their nature, forward-looking statements are subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections, or conclusions will not prove to be accurate, that assumptions may not be correct, and that objectives, strategic goals and priorities will not be achieved.  

Known and unknown risk factors, many of which are beyond the control of HEALWELL, could cause the actual results of HEALWELL to differ materially from the results, performance, achievements, or developments expressed or implied by such forward-looking statements. Such risk factors include but are not limited to those factors which are discussed under the section entitled “Risk Factors” in HEALWELL’s most recent annual information form dated April 1, 2024, which is available under HEALWELL’s SEDAR+ profile at www.sedarplus.com. The risk factors are not intended to represent a complete list of the factors that could affect HEALWELL and the reader is cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking statements. There can be no assurance that forward looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Forward-looking statements are provided for the purpose of providing information about management’s expectations and plans relating to the future. HEALWELL disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, or to explain any material difference between subsequent actual events and such forward-looking statements, except to the extent required by applicable law. All of the forward-looking statements contained in this press release are qualified by these cautionary statements. 

For more information:

Pardeep S. Sangha 
Investor Relations, HEALWELL AI Inc. 
Phone:  604-572-6392 
ir@healwell.ai 

Khure Health

Khure Health is a wholly owned subsidiary of HEALWELL AI. Khure is an AI health technology company whose precision medicine platform harnesses clinical data, enabling physicians to rapidly screen and identify patients with rare diseases and facilitate more personalized treatment.

Khure is actively working with and/or has rare and specialty disease programs in development with 6 of the top 10 pharma companies and international disease associations.
Visit Website →

This will close in 0 seconds

Pentavere

HEALWELL AI is a majority shareholder of Pentavere Research Group, a globally recognized and award-winning AI digital health company that has built a best-in-class AI engine to identify patients that are eligible for approved medications or interventions, to improve outcomes for patients and help drive therapy growth and penetration. Over the past several years, Pentavere has published an impressive array of literature in high-impact, peer-reviewed medical journals, totaling more than 30 manuscripts, which serve as a testament to Pentavere’s capabilities and adds significant credibility to their technology.
Visit Website →

This will close in 0 seconds

Intrahealth

Intrahealth is a pioneering force in healthcare technology, specializing in the development and implementation of state-of-the-art EMR solutions. With a relentless commitment to advancing patient care, Intrahealth empowers healthcare providers, institutions, and governments with innovative digital tools designed to enhance healthcare delivery and improve patient outcomes.
Visit Website →

This will close in 0 seconds

VeroSource Solutions

VeroSource Solutions is a digital health company established in 2014 to empower people and unlock the potential in Canadian healthcare. Its team of professionals has extensive experience in the full lifecycle of healthcare IT solutions and offers healthcare providers the technology and support needed to go digital. VeroSource’s cloud-first multi-channel software securely connects people, data and systems to drive digital healthcare transformation. Founded in Fredericton, NB, VeroSource has grown to include team members across Ontario and Atlantic Canadian.
Visit Website →

This will close in 0 seconds

BioPharma Services

BioPharma Services is a leading contract research organization (CRO) based in Toronto, Canada, specializing in Phase 1 and Phase 2a clinical trials. With a focus on scientific integrity, operational excellence, and adaptive processes tailored to each client’s needs, BioPharma Services has established a reputation for delivering high-quality results in the pharmaceutical and biotech industries. BioPharma’s comprehensive services also include Bioanalysis at their GLP Certified Laboratory, Scientific and Regulatory Affairs, Biostatistics and Safety Data Analysis (CDISC), Data Management and Medical Writing.
Visit Website →

This will close in 0 seconds

PolyClinic

HEALWELL AI Polyclinic provides onsite integrated health services including primary care, specialist care, lab services, and an in-house clinical research organization. With integrated systems and data-driven tools, HEALWELL AI Polyclinic plans to unlock meaningful insights from consistent, high-quality, structured clinical information from over 50 primary care physicians and specialists, labs, and clinical trials.
Visit Website →

This will close in 0 seconds

Doctorly

Founded in 2018, doctorly is a European based digital health-tech startup with a company mission of 'enabling people to live healthier lives'. With an initial focus on Europe’s largest market, Germany, doctorly has built a brand new, fully regulated practice management software to redefine how medical practices work. As an all-in-one solution, doctorly provides a fully centralised, cloud powered, GDPR compliant, medical practice operating system that dramatically reduces the time and effort doctors and medical assistants spend on day-to-day administrative tasks. doctorly is financially backed by some of the world’s most renowned venture capital firms. To learn more about doctorly please visit: www.doctorly.de

Read the original press release here.
Visit Website →

This will close in 0 seconds

xAI

xAI is a company working on building artificial intelligence to accelerate human scientific discovery. They're guided by their mission to advance our collective understanding of the universe. The team is led by Elon Musk, CEO of Tesla and SpaceX. Collectively their team has contributed some of the most widely used methods in the field, in particular the Adam optimizer, Batch Normalization, Layer Normalization, and the discovery of adversarial examples. They further introduced innovative techniques and analyses such as Transformer-XL, Autoformalization, the Memorizing Transformer, Batch Size Scaling, μTransfer, and SimCLR. They have worked on and led the development of some of the largest breakthroughs in the field including AlphaStar, AlphaCode, Inception, Minerva, GPT-3.5, and GPT-4. Learn more at https://x.ai/ Read the original press release here.
Visit Website →

This will close in 0 seconds

Mutuo Health Solutions

Mutuo Health Solutions is a Toronto-based medical artificial intelligence company focused on developing predictive clinical AI technology. Their flagship product, AutoScribe, is an advanced AI-powered ambient scribe solution that transcribes clinician-patient interactions into high-quality electronic medical records in real time. AutoScribe utilizes natural language processing and machine learning technology to accurately capture and structure patient data, enabling healthcare providers to focus on patient care and improve clinical efficiency.

Visit Website →

This will close in 0 seconds

Abstractive Health

Abstractive Health is on a mission to transform the healthcare industry by automating clinical documentation with generative AI. Their innovative AI software creates comprehensive patient summaries, streamlining workflows and empowering healthcare providers to focus on patient care. By harnessing advanced language models, the company delivers accurate, medically relevant insights directly to clinicians, enabling informed decision-making and improved patient outcomes. Read the original press release here. 

Visit Website →

This will close in 0 seconds